Posted: Friday, March 31, 2023
Alex K. Bryant, MD, of the University of Michigan, discusses study findings indicating that Veterans Administration facilities with lower prostate-specific antigen (PSA) screening rates had higher subsequent incidence rates of metastatic prostate cancer. He also discusses the rationale behind this observational study, screening guidelines, and some clinical pearls for clinicians.